Christopher Mutz - Feb 15, 2024 Form 4 Insider Report for ANI PHARMACEUTICALS INC (ANIP)

Role
HEAD OF RARE DISEASE
Signature
/s/ Christopher Mutz, by attorney-in-fact Meredith W. Cook
Stock symbol
ANIP
Transactions as of
Feb 15, 2024
Transactions value $
-$72,571
Form type
4
Date filed
2/20/2024, 05:02 PM
Previous filing
Feb 16, 2024
Next filing
Mar 1, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANIP Common Stock Tax liability -$72.6K -1.26K -1.33% $57.55 93.7K Feb 15, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 4,034 shares of restricted stock, the grant of which was previously reported.